Shares of Arkema SA (OTCMKTS:ARKAY - Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $67.01 and traded as low as $66.11. Arkema shares last traded at $67.88, with a volume of 3,030 shares changing hands.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Zacks Research downgraded shares of Arkema from a "hold" rating to a "strong sell" rating in a research report on Tuesday, January 6th. Kepler Capital Markets downgraded shares of Arkema from a "strong-buy" rating to a "hold" rating in a research report on Friday, February 27th. Finally, The Goldman Sachs Group upgraded Arkema from a "hold" rating to a "buy" rating in a research report on Tuesday, February 10th. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Reduce".
Get Our Latest Stock Report on ARKAY
Arkema Price Performance
The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.63 and a current ratio of 2.13. The stock has a market capitalization of $5.16 billion, a price-to-earnings ratio of 78.02, a P/E/G ratio of 1.64 and a beta of 0.84. The company has a 50-day moving average of $67.01 and a 200-day moving average of $62.80.
About Arkema
(
Get Free Report)
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total's chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema's operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.